Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kristal D. Atkins"'
Autor:
Tiffany N Eady, Ludmila Belayev, Larissa Khoutorova, Kristal D Atkins, Changde Zhang, Nicolas G Bazan
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e46151 (2012)
Docosahexaenoic acid, a major omega-3 essential fatty acid family member, improves behavioral deficit and reduces infarct volume and edema after experimental focal cerebral ischemia. We hypothesize that DHA elicits neuroprotection by inducing AKT/p70
Externí odkaz:
https://doaj.org/article/526678fbbe39441d9bb91dbb06fb85ec
Autor:
Charles N. Serhan, Yan Lu, Changde Zhang, Nicolas G. Bazan, Min Zhu, Kristal D. Atkins, Tiffany N. Eady, Gabrielle Fredman, Andre Obenaus, Jeremy W. Winkler, Larissa Khoutorova, Nicos A. Petasis, Song Hong, Ludmila Belayev, Bokkyoo Jun
Publikováno v:
Experimental Neurology. 236:122-130
Acute ischemic stroke triggers complex neurovascular, neuroinflammatory and synaptic alterations. Aspirin and docosahexaenoic acid (DHA), an omega-3 essential fatty acid family member, have beneficial effects on cerebrovascular diseases. DHA is the p
Publikováno v:
Stroke. 40:3121-3126
Background and Purpose— Docosahexaenoic acid (DHA; 22:6n-3), an ω-3 essential fatty acid family member, is the precursor of neuroprotectin D1, which downregulates apoptosis and, in turn, promotes cell survival. This study was conducted to assess w
Autor:
Kristal D. Atkins, Julio Alvarez-Builla, Nicolas G. Bazan, Ludmila Belayev, Larissa Khoutorova, William C. Gordon
Publikováno v:
e_Buah Biblioteca Digital Universidad de Alcalá
instname
instname
Platelet-activating factor (PAF) is a bioactive phospholipid that accumulates during ischemia-reperfusion and is involved in the activation of platelets, neutrophils, and pro-inflammatory signaling. PAF has been suggested to enhance brain ischemia-re
Autor:
Nicolas G Bazan, Tiffany N Eady, Larissa Khoutorova, Kristal D Atkins, Julio Alvarez-Builla, Ludmila Belayev
Publikováno v:
Stroke. 44
INTRODUCTION: Platelet-activating factor (PAF) is a bioactive phospholipid that regulates synaptic activity and when overproduced is a potent mediator of leukocyte functions, including platelet aggregation and inflammation. PAF concentration increase
Autor:
Larissa Khoutorova, Changde Zhang, Kristal D. Atkins, Ludmila Belayev, Nicolas G. Bazan, Tiffany N. Eady
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 10, p e46151 (2012)
PLoS ONE, Vol 7, Iss 10, p e46151 (2012)
Background Docosahexaenoic acid, a major omega-3 essential fatty acid family member, improves behavioral deficit and reduces infarct volume and edema after experimental focal cerebral ischemia. We hypothesize that DHA elicits neuroprotection by induc
Publikováno v:
Stroke. 43
Background and purpose: Docosahexaenoic acid (DHA), a member of the omega-3 essential fatty acid family, improves behavioral deficit and reduces infarct volume and brain edema after focal cerebral ischemia in rats. We hypothesize that DHA elicits neu
Publikováno v:
Stroke. 43
Background and Purpose: Recently we have shown that docosahexaenoic acid (DHA; 22:6, n-3) and human albumin (Alb) is neuroprotective after experimental stroke. However, administration of high-dose Alb by expanding intravascular volume may lead to pul
Autor:
Nicolas G Bazan, Charles N Serhan, Nicos A Petasis, Larissa Khoutorova, Kristal D Atkins, Tiffany N Eady, Song Hong, Bok Kyoo Jun, Andre Obenaus, Ludmila Belayev
Publikováno v:
Stroke. 43
Background and Purpose: Acute ischemic stroke triggers complex neurovascular, neuroinflammatory and synaptic alterations. Aspirin and the omega-3 essential fatty acid, docosahexaenoic acid (DHA), have beneficial effects on cerebrovascular diseases. U
Autor:
Nicolas G. Bazan, Larissa Khoutorova, Tiffany N. Eady, Kristal D. Atkins, Andre Obenaus, Julio Alvarez-Builla, Ludmila Belayev, Juan J. Vaquero, Marta Cordoba
Publikováno v:
Translational Stroke Research
Platelet-activating factor (PAF) accumulates during cerebral ischemia, and inhibition of this process plays a critical role in neuronal survival. Recently, we demonstrated that LAU-0901, a novel PAF receptor antagonist, is neuroprotective in experime